山东大学教师主页刘新泳论文成果中文主页

论文成果

[21] 郑义. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I/MDA-5 signaling. SIGNAL TRANSDUCTION AND TARGETED THERAPY, 5, 2020.
[22] 陈琳. Tetramethylpyrazine analogue CXC195 protects against cerebral ischemia/reperfusion-induced apoptosis through PI3K/Akt/GSK3β pathway in rats. Neurochem Int, 66, 27, 2014.
[23] 闫实. Tetramethylpyrazine Analogue CXC195 Ameliorates Cerebral Ischemia-reperfusion Injury by Regulating Endothelial Nitric Oxide Synthase Phosphorylation Via PI3K/Akt Signaling. NEUROCHEM RES, 40, 446, 2015.
[24] 展鹏. Structure-Based Bioisosterism Yields HIV-1 NNRTIs with Improved Drug-Resistance Profiles and Favorable Pharmacokinetic Properties. J Med Chem, 2020.
[25] 刘新泳. Strategies for the Discovery of Target-Specifific or Isoform-Selective Modulators. Journal of Medicinal Chemistry, 2015.
[26] 展鹏. Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion Channel. J Med Chem, 2020.
[27] 陶昱岑. Medicinal chemistry insights into novel CDC25 inhibitors. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 201, 2020.
[28] 展鹏. Design, Synthesis, and Mechanism Study of Benzenesulfonamide-Containing Phenylalanine Derivatives as Novel HIV-1 Capsid Inhibitors with Improved Antiviral Activities. J Med Chem, 2020.
[29] 展鹏. Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities.. J Med Chem, 2020.
[30] 刘新泳. Molecular design opportunities presented by solvent-exposed regions of target proteins. Med Res Rev., 2019.

共 568 条 3/57

首页上一页下一页尾页页

刘新泳

教授

性别：男

学历：博士研究生毕业

学位：博士

所在单位：药学院

入职时间： 1991-07

所属院系：药学院

版权所有 ©山东大学　地址：中国山东省济南市山大南路27号　邮编：250100　
查号台：（86）-0531-88395114
值班电话：（86）-0531-88364731　建设维护：山东大学信息化工作办公室　　
访问量：手机版 English 登录山东大学

最后更新时间： ..